InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: Lone Wolf post# 3663

Saturday, 05/27/2017 2:32:58 PM

Saturday, May 27, 2017 2:32:58 PM

Post# of 3898
Could be partially attributed to an analyst cutting price target but kept outperform rating.

https://www.smarteranalyst.com/2017/05/26/rexahn-pharmaceuticals-inc-rnn-challenged-financing-overhang-fbr-slashed-price-target/